Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apomorphine Infusion for Visual Hallucinations in PD
NCT02702076Phase 2Unknown
- Sponsor
- University Medical Center Groningen
- Start
- May 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Apomorphine with Placebo (2 arms). Primary endpoint: Clinical Global Impression of Severity at 4 weeks. Status: unknown.
02
Drugs
apomorphine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02702076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02702076.